PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 121 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $275,000 | -21.4% | 72,429 | +5.3% | 0.00% | 0.0% |
| Q4 2019 | $350,000 | +2.0% | 68,813 | +1.3% | 0.00% | 0.0% |
| Q3 2019 | $343,000 | -16.1% | 67,902 | +2.4% | 0.00% | 0.0% |
| Q2 2019 | $409,000 | +36.8% | 66,326 | +2.9% | 0.00% | 0.0% |
| Q1 2019 | $299,000 | +20.1% | 64,488 | +8.6% | 0.00% | 0.0% |
| Q4 2018 | $249,000 | -31.6% | 59,369 | +2.2% | 0.00% | 0.0% |
| Q3 2018 | $364,000 | -10.6% | 58,064 | +14.8% | 0.00% | 0.0% |
| Q2 2018 | $407,000 | +18.7% | 50,571 | +10.0% | 0.00% | 0.0% |
| Q1 2018 | $343,000 | +33.5% | 45,972 | +6.3% | 0.00% | 0.0% |
| Q4 2017 | $257,000 | -17.6% | 43,263 | +2.0% | 0.00% | 0.0% |
| Q3 2017 | $312,000 | +8.3% | 42,410 | +0.1% | 0.00% | 0.0% |
| Q2 2017 | $288,000 | -23.0% | 42,380 | +6.8% | 0.00% | -50.0% |
| Q1 2017 | $374,000 | -16.9% | 39,670 | -61.6% | 0.00% | 0.0% |
| Q1 2016 | $450,000 | -28.9% | 103,280 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $633,000 | – | 103,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|